• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉造影或血管成形术患者预防对比剂肾病的口服与静脉补液策略比较:一项随机临床试验

Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial.

作者信息

Kong De-Gui, Hou Yan-Fang, Ma Long-Le, Yao Dao-Kuo, Wang Le-Xin

机构信息

Department of Cardiology, Liaocheng People's Hospital of Taishan Medical University, Liaocheng, Shandong, P.R. China.

出版信息

Acta Cardiol. 2012 Oct;67(5):565-9. doi: 10.1080/ac.67.5.2174131.

DOI:10.1080/ac.67.5.2174131
PMID:23252007
Abstract

OBJECTIVE

The efficacy of oral hydration in the prevention of contrast-induced nephropathy in patients undergoing elective coronary intervention is unclear.

METHODS

A total of 120 patients were randomly assigned to three groups. Group A (n = 40) received intravenous hydration before and after coronary angiography or angioplasty. Group B (n = 40) received oral tap water before and after the procedures, whereas group C (n = 40) received only postprocedural drinking water. Levels of serum creatinine and urea nitrogen were measured before, 12 hours after, 2 and 3 days after the coronary angiography or angioplasty.

RESULTS

: There was no statistically significant difference in the age, sex, baseline renal function and the volume of contrast medium used during the coronary procedures among the three groups (P > 0.05).There was no statistically significant difference in the mean serum creatinine or urea nitrogen among the three groups 12 hours, and 3 days after the coronary procedures ( P > 0.05).The incidence of contrast-induced nephropathy in group A, B and C was 5.0% (2/40), 7.5% (3/40) and 5.0% (2/40), respectively (P = 0.86). Renal function in the seven patients who experienced contrast-induced nephropathy recovered within a week following rehydration treatment.

CONCLUSIONS

Pre- and post-procedural oral hydration was as effective as intravenous rehydration in the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty.

摘要

目的

口服补液对接受择期冠状动脉介入治疗患者预防造影剂肾病的疗效尚不清楚。

方法

总共120例患者被随机分为三组。A组(n = 40)在冠状动脉造影或血管成形术前及术后接受静脉补液。B组(n = 40)在操作前后饮用自来水,而C组(n = 40)仅在术后饮水。在冠状动脉造影或血管成形术前、术后12小时、2天和3天测量血清肌酐和尿素氮水平。

结果

三组患者的年龄、性别、基线肾功能以及冠状动脉操作期间使用的造影剂剂量无统计学显著差异(P > 0.05)。冠状动脉操作后12小时和3天,三组患者的平均血清肌酐或尿素氮无统计学显著差异(P > 0.05)。A组、B组和C组造影剂肾病的发生率分别为5.0%(2/40)、7.5%(3/40)和5.0%(2/40)(P = 0.86)。七例发生造影剂肾病患者的肾功能在补液治疗后一周内恢复。

结论

在接受冠状动脉造影或血管成形术的患者中,术前及术后口服补液在预防造影剂肾病方面与静脉补液同样有效。

相似文献

1
Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial.冠状动脉造影或血管成形术患者预防对比剂肾病的口服与静脉补液策略比较:一项随机临床试验
Acta Cardiol. 2012 Oct;67(5):565-9. doi: 10.1080/ac.67.5.2174131.
2
Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.静脉注射 N-乙酰半胱氨酸联合高剂量水化与高剂量水化和标准水化预防对比剂肾病:CASIS——一项多中心前瞻性对照试验。
Int J Cardiol. 2012 Mar 22;155(3):418-23. doi: 10.1016/j.ijcard.2010.10.041. Epub 2010 Nov 23.
3
Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.水化联合或不联合N-乙酰半胱氨酸对接受冠状动脉造影和经皮冠状动脉介入治疗患者造影剂肾病的影响。
Mymensingh Med J. 2011 Apr;20(2):264-9.
4
Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.单次静脉推注碳酸氢钠对预防择期冠状动脉手术的轻度肾功能不全患者造影剂肾病的疗效。
Am J Cardiol. 2009 Oct 1;104(7):921-5. doi: 10.1016/j.amjcard.2009.05.034.
5
Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.对比剂相关性肾病的预防:1620例接受冠状动脉血管成形术患者中两种水化方案的随机对照研究
Arch Intern Med. 2002 Feb 11;162(3):329-36. doi: 10.1001/archinte.162.3.329.
6
Comparison between three supportive treatments for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography.三种支持性治疗对接受冠状动脉造影的高危患者预防造影剂肾病的比较。
Saudi J Kidney Dis Transpl. 2014 Nov;25(6):1217-23. doi: 10.4103/1319-2442.144255.
7
N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.N-乙酰半胱氨酸和/或抗坏血酸与安慰剂用于预防择期心脏导管插入术患者造影剂肾病:NAPCIN试验;一项单中心、前瞻性、随机试验
Saudi J Kidney Dis Transpl. 2016 Jan;27(1):55-61. doi: 10.4103/1319-2442.174072.
8
[Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].[预防水化以保护对比剂肾病高危患者的肾功能免受血管内碘化造影剂损害(AMACING):一项前瞻性、随机、3期、对照、开放标签、非劣效性试验]
Ned Tijdschr Geneeskd. 2018;161:D1734.
9
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.预防性水化以保护高危对比剂肾病(AMACING)患者的肾功能免受血管内碘造影剂影响:一项前瞻性、随机、3 期、对照、开放标签、非劣效性试验。
Lancet. 2017 Apr 1;389(10076):1312-1322. doi: 10.1016/S0140-6736(17)30057-0. Epub 2017 Feb 21.
10
Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.择期经皮冠状动脉和外周血管介入治疗的稳定型慢性肾脏病患者中对比剂诱导的急性肾损伤的预防:两种预防策略的随机比较。
Catheter Cardiovasc Interv. 2012 May 1;79(6):929-37. doi: 10.1002/ccd.23148. Epub 2011 Dec 8.

引用本文的文献

1
Simplified rapid hydration and contrast-associated acute kidney injury among CKD patients stratified by Mehran score: sub-analysis from the TIME Trial.根据梅兰评分分层的慢性肾脏病患者简化快速水化与造影剂相关急性肾损伤:TIME试验的亚组分析
Perioper Med (Lond). 2024 Oct 14;13(1):103. doi: 10.1186/s13741-024-00462-z.
2
Effectiveness of Oral Hydration in Preventing Contrast-Induced Nephropathy in Individuals Undergoing Elective Coronary Interventions.口服补液预防择期冠状动脉介入治疗患者对比剂肾病的效果。
Arq Bras Cardiol. 2023 Feb 27;120(2):e20220529. doi: 10.36660/abc.20220529. eCollection 2023.
3
Evaluating the Effectiveness of Pretreatment With Intravenous Fluid in Reducing the Risk of Developing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.
评估静脉输液预处理在降低对比剂诱导的肾病发生风险中的有效性:一项系统评价和荟萃分析。
Cureus. 2022 May 8;14(5):e24825. doi: 10.7759/cureus.24825. eCollection 2022 May.
4
The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy.放射性造影剂所致肾病的病理生理学与管理
Diagnostics (Basel). 2022 Jan 12;12(1):180. doi: 10.3390/diagnostics12010180.
5
Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR study.口服水化作为一种安全的预防措施,可预防接受增强 CT 检查的慢性肾脏病(IIIb 期)肿瘤患者的造影剂相关急性肾损伤:NICIR 研究肿瘤组的亚组分析。
Support Care Cancer. 2022 Feb;30(2):1879-1887. doi: 10.1007/s00520-021-06561-7. Epub 2021 Oct 6.
6
[Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology].[造影剂诱导的急性肾损伤——德国心脏病学会和德国肾脏病学会“心脏与肾脏”工作组共识文件]
Internist (Berl). 2021 Jan;62(1):111-120. doi: 10.1007/s00108-020-00938-2.
7
Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis.水化策略预防对比剂急性肾损伤:系统评价和贝叶斯网状 Meta 分析。
J Interv Cardiol. 2020 Feb 11;2020:7292675. doi: 10.1155/2020/7292675. eCollection 2020.
8
Evaluation of neutral oral contrast agents for assessment of the small bowel at abdominal staging CT.评估中性口服对比剂在腹部分期 CT 中小肠评估中的应用。
PLoS One. 2019 Nov 14;14(11):e0225160. doi: 10.1371/journal.pone.0225160. eCollection 2019.
9
Guideline on the use of iodinated contrast media in patients with kidney disease 2018.《2018年肾病患者使用碘化造影剂指南》
Jpn J Radiol. 2020 Jan;38(1):3-46. doi: 10.1007/s11604-019-00850-2.
10
Guideline on the use of iodinated contrast media in patients with kidney disease 2018.《2018年肾病患者使用碘化造影剂指南》
Clin Exp Nephrol. 2020 Jan;24(1):1-44. doi: 10.1007/s10157-019-01750-5.